Loading clinical trials...
Loading clinical trials...
A Post-Approval Multicenter Study to Assess the Continued Safety and Effectiveness of the AeroPace® System - The AERO-PAS Study
A single-arm, prospective, multicenter cohort study to assess the 30-day continued safety and effectiveness of the AeroPace System in patients on mechanical ventilation (MV) at least 96 hours and who have not weaned. This is a study collecting real-world data in a post-market setting.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Start Date
July 1, 2026
Primary Completion Date
February 1, 2028
Completion Date
February 1, 2028
Last Updated
March 17, 2026
120
ESTIMATED participants
Lungpacer Diaphragm Pacing Therapy
DEVICE
Lead Sponsor
Lungpacer Medical Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions